{"id":3983,"date":"2020-09-15T13:52:33","date_gmt":"2020-09-15T12:52:33","guid":{"rendered":"https:\/\/www.ab-science.com\/accueil\/"},"modified":"2025-05-21T11:28:26","modified_gmt":"2025-05-21T10:28:26","slug":"accueil","status":"publish","type":"page","link":"https:\/\/www.ab-science.com\/fr\/","title":{"rendered":"Accueil"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row css=\u00a0\u00bb.vc_custom_1601559325217{margin-top: 0px !important;padding-top: 0px !important;}\u00a0\u00bb][vc_column]\n\t\t\t<!-- START Slider 1 REVOLUTION SLIDER 6.7.38 --><p class=\"rs-p-wp-fix\"><\/p>\n\t\t\t<rs-module-wrap id=\"rev_slider_2_1_wrapper\" data-source=\"gallery\" style=\"visibility:hidden;background:transparent;padding:0;margin:0px auto;margin-top:0;margin-bottom:0;\">\n\t\t\t\t<rs-module id=\"rev_slider_2_1\" style=\"\" data-version=\"6.7.38\">\n\t\t\t\t\t<rs-slides style=\"overflow: hidden; position: absolute;\">\n\t\t\t\t\t\t<rs-slide style=\"position: absolute;\" data-key=\"rs-2\" data-title=\"Slide\" data-anim=\"adpr:false;\" data-in=\"o:0;\" data-out=\"a:false;\">\n\t\t\t\t\t\t\t<img decoding=\"async\" src=\"\/\/www.ab-science.com\/wp-content\/plugins\/revslider\/sr6\/assets\/assets\/dummy.png\" alt=\"\" title=\"Water molecules. Science or medical background with molecules and atoms. 3d render\" width=\"2560\" height=\"1440\" class=\"rev-slidebg tp-rs-img rs-lazyload\" data-lazyload=\"\/\/www.ab-science.com\/wp-content\/uploads\/2023\/02\/water-molecules-science-or-medical-background-wit-2022-12-16-21-47-06-utc-scaled.jpg\" data-no-retina>\n<!--\n\t\t\t\t\t\t\t--><rs-layer\n\t\t\t\t\t\t\t\tid=\"slider-2-slide-2-layer-0\" \n\t\t\t\t\t\t\t\tdata-type=\"text\"\n\t\t\t\t\t\t\t\tdata-color=\"#ffffff\"\n\t\t\t\t\t\t\t\tdata-tsh=\"c:rgba(0,0,0,0.93);h:2px;v:5px;b:15px;\"\n\t\t\t\t\t\t\t\tdata-rsp_ch=\"on\"\n\t\t\t\t\t\t\t\tdata-xy=\"x:r;xo:57px;y:c;yo:30px;\"\n\t\t\t\t\t\t\t\tdata-text=\"w:normal;s:42;l:52;ls:0px;fw:900;\"\n\t\t\t\t\t\t\t\tdata-dim=\"w:560px;minh:0px;\"\n\t\t\t\t\t\t\t\tdata-frame_999=\"o:0;st:w;sR:8700;\"\n\t\t\t\t\t\t\t\tstyle=\"z-index:8;font-family:'Lato';text-transform:uppercase;\"\n\t\t\t\t\t\t\t>D\u00e9velopper des th\u00e9rapies innovantes dans des maladies \u00e0 fort besoin m\u00e9dical \n\t\t\t\t\t\t\t<\/rs-layer><!--\n-->\t\t\t\t\t<\/rs-slide>\n\t\t\t\t\t<\/rs-slides>\n\t\t\t\t<\/rs-module>\n\t\t\t\t<script>\n\t\t\t\t\tsetREVStartSize({c: 'rev_slider_2_1',rl:[1240,1024,778,480],el:[620],gw:[1240],gh:[620],type:'standard',justify:'',layout:'fullwidth',mh:\"0\"});if (window.RS_MODULES!==undefined && window.RS_MODULES.modules!==undefined && window.RS_MODULES.modules[\"revslider21\"]!==undefined) {window.RS_MODULES.modules[\"revslider21\"].once = false;window.revapi2 = undefined;if (window.RS_MODULES.checkMinimal!==undefined) window.RS_MODULES.checkMinimal()}\n\t\t\t\t<\/script>\n\t\t\t<\/rs-module-wrap>\n\t\t\t<!-- END REVOLUTION SLIDER -->\n[\/vc_column][\/vc_row][vc_row][vc_column]<div class=\"ult-spacer spacer-69f6e041530f4\" data-id=\"69f6e041530f4\" data-height=\"40\" data-height-mobile=\"20\" data-height-tab=\"40\" data-height-tab-portrait=\"20\" data-height-mobile-landscape=\"20\" style=\"clear:both;display:block;\"><\/div>[\/vc_column][\/vc_row][vc_row][vc_column]<div class=\"dt-fancy-separator h2-size accent-title-color accent-border-color\" style=\"width: 100%;\"><div class=\"dt-fancy-title\"><span class=\"separator-holder separator-left\"><\/span>Derni\u00e8res actualit\u00e9s<span class=\"separator-holder separator-right\"><\/span><\/div><\/div><div class=\"ult-spacer spacer-69f6e04153526\" data-id=\"69f6e04153526\" data-height=\"20\" data-height-mobile=\"10\" data-height-tab=\"20\" data-height-tab-portrait=\"20\" data-height-mobile-landscape=\"10\" style=\"clear:both;display:block;\"><\/div><style type=\"text\/css\" data-type=\"the7_shortcodes-inline-css\">.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.dividers-on.classic-layout-list article {\n  padding-top: 0;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.dividers-on.classic-layout-list article:first-of-type {\n  margin-top: 0;\n  padding-top: 0;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.classic-layout-list.mode-list .post-entry-content {\n  width: calc(100% - );\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.classic-layout-list.mode-list .no-img .post-entry-content {\n  width: 100%;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .filter-bg-decoration .filter-categories a.act {\n  color: #fff;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.mode-masonry) article:first-of-type,\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.mode-masonry) article.visible.first:not(.product) {\n  margin-top: 0;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.dividers-on:not(.mode-masonry) article {\n  margin-top: 0;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.dividers-on:not(.mode-masonry) article:first-of-type,\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.dividers-on:not(.mode-masonry) article.visible.first:not(.product) {\n  margin-top: 0;\n  padding-top: 0;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .post-thumbnail-wrap {\n  padding: 0px 0px 0px 0px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.enable-bg-rollover .post-thumbnail-rollover:after {\n  background: -webkit-linear-gradient();\n  background: linear-gradient();\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico {\n  width: 44px;\n  height: 44px;\n  line-height: 44px;\n  border-radius: 100px;\n  margin: -22px 0 0 -22px;\n  border-width: 0px;\n  color: #ffffff;\n}\n.bottom-overlap-layout-list.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico {\n  margin-top: -72px;\n}\n.gradient-overlay-layout-list.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico,\n.content-rollover-layout-list.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico {\n  margin: 0 0 10px;\n}\n.content-align-center.gradient-overlay-layout-list.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico,\n.content-align-center.content-rollover-layout-list.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico {\n  margin: 0 auto 10px;\n}\n.dt-icon-bg-on.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico {\n  background: rgba(255,255,255,0.3);\n  box-shadow: none;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico > span,\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico:before {\n  font-size: 32px;\n  line-height: 44px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico > span,\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .gallery-zoom-ico:before {\n  color: #ffffff;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .entry-title,\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.owl-carousel .entry-title {\n  margin-bottom: 5px;\n  font-weight: bold;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .entry-meta {\n  margin-bottom: 15px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .portfolio-categories {\n  margin-bottom: 15px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .entry-excerpt {\n  margin-bottom: 5px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.centered-layout-list) .post-entry-content {\n  padding: 25px 30px 30px 30px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.centered-layout-list):not(.content-bg-on):not(.mode-list) .no-img .post-entry-content {\n  padding: 0;\n}\n@media screen and (max-width: ) {\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 article {\n    -ms-flex-flow: column nowrap;\n    flex-flow: column nowrap;\n    margin-top: 20px;\n  }\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.dividers-on article {\n    border: none;\n  }\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.content-bg-on.centered-layout-list article {\n    padding: 0;\n  }\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.blog-shortcode.dividers-on article,\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.dividers-on.classic-layout-list article {\n    margin-top: 20px;\n    padding: 0;\n  }\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.blog-shortcode.dividers-on article:first-of-type,\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.dividers-on.classic-layout-list article:first-of-type {\n    padding: 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .post-thumbnail-wrap,\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .post-entry-content {\n    width: 100%;\n    margin: 0;\n    top: 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .post-thumbnail-wrap {\n    padding: 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .post-entry-content:after {\n    display: none;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .project-even .post-thumbnail-wrap,\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.centered-layout-list .post-thumbnail-wrap {\n    -ms-flex-order: 0;\n    order: 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.centered-layout-list .post-entry-title-content {\n    -ms-flex-order: 1;\n    order: 1;\n    width: 100%;\n    padding: 20px 20px 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.centered-layout-list .post-entry-content {\n    -ms-flex-order: 2;\n    order: 2;\n    padding-top: 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .fancy-categories {\n    top: 10px;\n    left: 10px;\n    bottom: auto;\n    right: auto;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .fancy-date a {\n    top: 10px;\n    right: 10px;\n    left: auto;\n    bottom: auto;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .post-entry-content {\n    padding: 20px;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .entry-title {\n    margin: 3px 0 5px;\n    font-size: 20px;\n    line-height: 26px;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .entry-meta {\n    margin: 5px 0 5px;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .entry-excerpt {\n    margin: 15px 0 0;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .post-details {\n    margin: 5px 0 10px;\n  }\n  #page .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 .post-details.details-type-link {\n    margin-bottom: 2px;\n  }\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.resize-by-browser-width) .dt-css-grid {\n  grid-row-gap: 30px;\n  grid-column-gap: 30px;\n  grid-template-columns: repeat(auto-fill,minmax(,1fr));\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.resize-by-browser-width) .dt-css-grid .double-width {\n  grid-column: span 2;\n}\n.cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.resize-by-browser-width) .dt-css-grid,\n.no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.resize-by-browser-width) .dt-css-grid {\n  display: flex;\n  flex-flow: row wrap;\n  margin: -15px;\n}\n.cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.resize-by-browser-width) .dt-css-grid .wf-cell,\n.no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2:not(.resize-by-browser-width) .dt-css-grid .wf-cell {\n  flex: 1 0 ;\n  max-width: 100%;\n  padding: 15px;\n  box-sizing: border-box;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid {\n  grid-template-columns: repeat(3,1fr);\n  grid-template-rows: auto;\n  grid-column-gap: 30px;\n  grid-row-gap: 30px;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .double-width {\n  grid-column: span 2;\n}\n.cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid {\n  margin: -15px;\n}\n.cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell {\n  width: 33.333333333333%;\n  padding: 15px;\n}\n.cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell.double-width {\n  width: calc(33.333333333333%) * 2;\n}\n.blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width:not(.centered-layout-list):not(.content-bg-on) .dt-css-grid {\n  grid-row-gap: 0px;\n}\n@media screen and (max-width: 1199px) {\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid {\n    grid-template-columns: repeat(3,1fr);\n  }\n  .cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell,\n  .no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell {\n    width: 33.333333333333%;\n  }\n  .cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell.double-width,\n  .no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell.double-width {\n    width: calc(33.333333333333%)*2;\n  }\n}\n@media screen and (max-width: 991px) {\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid {\n    grid-template-columns: repeat(2,1fr);\n  }\n  .cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell,\n  .no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell {\n    width: 50%;\n  }\n  .cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell.double-width,\n  .no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell.double-width {\n    width: calc(50%)*2;\n  }\n}\n@media screen and (max-width: 767px) {\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid {\n    grid-template-columns: repeat(1,1fr);\n  }\n  .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .double-width {\n    grid-column: span 1;\n  }\n  .cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell,\n  .no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell {\n    width: 100%;\n  }\n  .cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell.double-width,\n  .no-cssgridlegacy.no-cssgrid .blog-shortcode.blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2.resize-by-browser-width .dt-css-grid .wf-cell.double-width {\n    width: calc(100%)*2;\n  }\n}<\/style><div class=\"blog-shortcode blog-masonry-shortcode-id-c66f480434dacdd7f756afcaa9eb23f2 mode-grid classic-layout-list content-bg-on jquery-filter scale-img dt-css-grid-wrap dt-icon-bg-off resize-by-browser-width loading-effect-move-up description-under-image \" data-padding=\"15px\" data-cur-page=\"1\" data-post-limit=\"-1\" data-pagination-mode=\"none\" data-desktop-columns-num=\"3\" data-v-tablet-columns-num=\"2\" data-h-tablet-columns-num=\"3\" data-phone-columns-num=\"1\" data-width=\"0px\" data-columns=\"0\"><div class=\"dt-css-grid\" ><div class=\"visible wf-cell\" data-post-id=\"10652\" data-date=\"2026-04-29T07:55:19+02:00\" data-name=\"AB Science annonce le succ\u00e8s d\u2019un placement prive de 3,2 millions d\u2019euros\"><article class=\"post project-odd visible no-img post-10652 type-post status-publish format-standard hentry category-2026-fr category-138\" data-name=\"AB Science annonce le succ\u00e8s d\u2019un placement prive de 3,2 millions d\u2019euros\" data-date=\"2026-04-29T07:55:19+02:00\">\n\n<div class=\"post-entry-content\">\n\n\t<h3 class=\"entry-title\">\n\t\t<a href=\"https:\/\/www.ab-science.com\/fr\/ab-science-annonce-le-succes-dun-placement-prive-de-32-millions-deuros\/\" title=\"AB Science annonce le succ\u00e8s d\u2019un placement prive de 3,2 millions d\u2019euros\" rel=\"bookmark\">AB Science annonce le succ\u00e8s d\u2019un placement prive de 3,2 millions d\u2019euros<\/a>\n\t<\/h3>\n\n\t<div class=\"entry-meta\"><a href=\"https:\/\/www.ab-science.com\/fr\/2026\/04\/29\/\" title=\"7h55\" class=\"data-link\" rel=\"bookmark\"><time class=\"entry-date updated\" datetime=\"2026-04-29T07:55:19+02:00\">29 avril 2026<\/time><\/a><\/div>\n\t<div class=\"entry-excerpt\"><p>[vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb] 29\/04\/2026 \u2013\u00a0AB Science annonce aujourd&rsquo;hui le succ\u00e8s d&rsquo;une augmentation de capital d&rsquo;un montant brut total de 3,2 millions d\u2019euros souscrite par un nombre limit\u00e9 d&rsquo;investisseurs [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n<\/div>\n\t\n<a href=\"https:\/\/www.ab-science.com\/fr\/ab-science-annonce-le-succes-dun-placement-prive-de-32-millions-deuros\/\" class=\"post-details details-type-link\" aria-label=\"Read more about AB Science annonce le succ\u00e8s d\u2019un placement prive de 3,2 millions d\u2019euros\">Lire la suite<i class=\"dt-icon-the7-arrow-03\" aria-hidden=\"true\"><\/i><\/a>\n\n<\/div><\/article><\/div><div class=\"visible wf-cell\" data-post-id=\"10640\" data-date=\"2026-04-27T18:01:06+02:00\" data-name=\"AB Science annonce un accord final sur la ren\u00e9gociation des modalit\u00e9s de remboursement de ses emprunts avec l\u2019ensemble de ses cr\u00e9anciers financiers\"><article class=\"post project-odd visible no-img post-10640 type-post status-publish format-standard hentry category-2026-fr category-138\" data-name=\"AB Science annonce un accord final sur la ren\u00e9gociation des modalit\u00e9s de remboursement de ses emprunts avec l\u2019ensemble de ses cr\u00e9anciers financiers\" data-date=\"2026-04-27T18:01:06+02:00\">\n\n<div class=\"post-entry-content\">\n\n\t<h3 class=\"entry-title\">\n\t\t<a href=\"https:\/\/www.ab-science.com\/fr\/ab-science-annonce-un-accord-final-sur-la-renegociation-des-modalites-de-remboursement-de-ses-emprunts-avec-lensemble-de-ses-creanciers-financiers\/\" title=\"AB Science annonce un accord final sur la ren\u00e9gociation des modalit\u00e9s de remboursement de ses emprunts avec l\u2019ensemble de ses cr\u00e9anciers financiers\" rel=\"bookmark\">AB Science annonce un accord final sur la ren\u00e9gociation des modalit\u00e9s de remboursement de ses emprunts avec l\u2019ensemble de ses cr\u00e9anciers financiers<\/a>\n\t<\/h3>\n\n\t<div class=\"entry-meta\"><a href=\"https:\/\/www.ab-science.com\/fr\/2026\/04\/27\/\" title=\"18h01\" class=\"data-link\" rel=\"bookmark\"><time class=\"entry-date updated\" datetime=\"2026-04-27T18:01:06+02:00\">27 avril 2026<\/time><\/a><\/div>\n\t<div class=\"entry-excerpt\"><p>[vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb] 27\/04\/2026 \u2013\u00a0AB Science annonce aujourd&rsquo;hui qu&rsquo;un accord d\u00e9finitif a \u00e9t\u00e9 obtenu avec ses cr\u00e9anciers financiers en vue du d\u00e9calage de 24 mois du remboursement de sa dette bancaire et du d\u00e9calage de 12 mois du remboursement d\u2019un pr\u00eat souscrit aupr\u00e8s de la BEI [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n<\/div>\n\t\n<a href=\"https:\/\/www.ab-science.com\/fr\/ab-science-annonce-un-accord-final-sur-la-renegociation-des-modalites-de-remboursement-de-ses-emprunts-avec-lensemble-de-ses-creanciers-financiers\/\" class=\"post-details details-type-link\" aria-label=\"Read more about AB Science annonce un accord final sur la ren\u00e9gociation des modalit\u00e9s de remboursement de ses emprunts avec l\u2019ensemble de ses cr\u00e9anciers financiers\">Lire la suite<i class=\"dt-icon-the7-arrow-03\" aria-hidden=\"true\"><\/i><\/a>\n\n<\/div><\/article><\/div><div class=\"visible wf-cell\" data-post-id=\"10627\" data-date=\"2026-04-20T21:29:14+02:00\" data-name=\"Nouvelle publication sur medrxiv d\u00e9montrant des b\u00e9n\u00e9fices substantiels en termes de survie et de qualit\u00e9 de vie pr\u00e9serv\u00e9e avec le masitinib chez les patients atteints de SLA\"><article class=\"post project-odd visible no-img post-10627 type-post status-publish format-standard hentry category-2026-fr category-138\" data-name=\"Nouvelle publication sur medrxiv d\u00e9montrant des b\u00e9n\u00e9fices substantiels en termes de survie et de qualit\u00e9 de vie pr\u00e9serv\u00e9e avec le masitinib chez les patients atteints de SLA\" data-date=\"2026-04-20T21:29:14+02:00\">\n\n<div class=\"post-entry-content\">\n\n\t<h3 class=\"entry-title\">\n\t\t<a href=\"https:\/\/www.ab-science.com\/fr\/nouvelle-publication-sur-medrxiv-demontrant-des-benefices-substantiels-en-termes-de-survie-et-de-qualite-de-vie-preservee-avec-le-masitinib-chez-les-patients-atteints-de-sla\/\" title=\"Nouvelle publication sur medrxiv d\u00e9montrant des b\u00e9n\u00e9fices substantiels en termes de survie et de qualit\u00e9 de vie pr\u00e9serv\u00e9e avec le masitinib chez les patients atteints de SLA\" rel=\"bookmark\">Nouvelle publication sur medrxiv d\u00e9montrant des b\u00e9n\u00e9fices substantiels en termes de survie et de qualit\u00e9 de vie pr\u00e9serv\u00e9e avec le masitinib chez les patients atteints de SLA<\/a>\n\t<\/h3>\n\n\t<div class=\"entry-meta\"><a href=\"https:\/\/www.ab-science.com\/fr\/2026\/04\/20\/\" title=\"21h29\" class=\"data-link\" rel=\"bookmark\"><time class=\"entry-date updated\" datetime=\"2026-04-20T21:29:14+02:00\">20 avril 2026<\/time><\/a><\/div>\n\t<div class=\"entry-excerpt\"><p>[vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb] 20\/04\/2026 \u2013\u00a0AB Science annonce la publication d&rsquo;un nouvel article sur la plateforme de pr\u00e9publication medRxiv, \u00e9valuant les survivants \u00e0 long terme de la SLA trait\u00e9s par le masitinib \u00e0 la dose de 4,5 mg\/kg\/jour dans l&rsquo;\u00e9tude de phase 2b\/3 AB10015 [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n<\/div>\n\t\n<a href=\"https:\/\/www.ab-science.com\/fr\/nouvelle-publication-sur-medrxiv-demontrant-des-benefices-substantiels-en-termes-de-survie-et-de-qualite-de-vie-preservee-avec-le-masitinib-chez-les-patients-atteints-de-sla\/\" class=\"post-details details-type-link\" aria-label=\"Read more about Nouvelle publication sur medrxiv d\u00e9montrant des b\u00e9n\u00e9fices substantiels en termes de survie et de qualit\u00e9 de vie pr\u00e9serv\u00e9e avec le masitinib chez les patients atteints de SLA\">Lire la suite<i class=\"dt-icon-the7-arrow-03\" aria-hidden=\"true\"><\/i><\/a>\n\n<\/div><\/article><\/div><div class=\"visible wf-cell\" data-post-id=\"10620\" data-date=\"2026-04-16T19:16:53+02:00\" data-name=\"Point sur le programme de d\u00e9veloppement clinique d\u2019AB Science\"><article class=\"post project-odd visible no-img post-10620 type-post status-publish format-standard hentry category-2026-fr category-138\" data-name=\"Point sur le programme de d\u00e9veloppement clinique d\u2019AB Science\" data-date=\"2026-04-16T19:16:53+02:00\">\n\n<div class=\"post-entry-content\">\n\n\t<h3 class=\"entry-title\">\n\t\t<a href=\"https:\/\/www.ab-science.com\/fr\/point-sur-le-programme-de-developpement-clinique-dab-science\/\" title=\"Point sur le programme de d\u00e9veloppement clinique d\u2019AB Science\" rel=\"bookmark\">Point sur le programme de d\u00e9veloppement clinique d\u2019AB Science<\/a>\n\t<\/h3>\n\n\t<div class=\"entry-meta\"><a href=\"https:\/\/www.ab-science.com\/fr\/2026\/04\/16\/\" title=\"19h16\" class=\"data-link\" rel=\"bookmark\"><time class=\"entry-date updated\" datetime=\"2026-04-16T19:16:53+02:00\">16 avril 2026<\/time><\/a><\/div>\n\t<div class=\"entry-excerpt\"><p>[vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb] 16\/04\/2026 \u2013\u00a0AB Science fait le point sur son programme de d\u00e9veloppement clinique [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n<\/div>\n\t\n<a href=\"https:\/\/www.ab-science.com\/fr\/point-sur-le-programme-de-developpement-clinique-dab-science\/\" class=\"post-details details-type-link\" aria-label=\"Read more about Point sur le programme de d\u00e9veloppement clinique d\u2019AB Science\">Lire la suite<i class=\"dt-icon-the7-arrow-03\" aria-hidden=\"true\"><\/i><\/a>\n\n<\/div><\/article><\/div><div class=\"visible wf-cell\" data-post-id=\"10585\" data-date=\"2026-02-24T17:52:32+01:00\" data-name=\"AB Science annonce l&#039;identification d&#039;un biomarqueur plasmatique marqueur de l&#039;activit\u00e9 du masitinib dans le traitement de la SLA\"><article class=\"post project-odd visible no-img post-10585 type-post status-publish format-standard hentry category-2026-fr category-138\" data-name=\"AB Science annonce l&rsquo;identification d&rsquo;un biomarqueur plasmatique marqueur de l&rsquo;activit\u00e9 du masitinib dans le traitement de la SLA\" data-date=\"2026-02-24T17:52:32+01:00\">\n\n<div class=\"post-entry-content\">\n\n\t<h3 class=\"entry-title\">\n\t\t<a href=\"https:\/\/www.ab-science.com\/fr\/ab-science-annonce-lidentification-dun-biomarqueur-plasmatique-marqueur-de-lactivite-du-masitinib-dans-le-traitement-de-la-sla\/\" title=\"AB Science annonce l&rsquo;identification d&rsquo;un biomarqueur plasmatique marqueur de l&rsquo;activit\u00e9 du masitinib dans le traitement de la SLA\" rel=\"bookmark\">AB Science annonce l&rsquo;identification d&rsquo;un biomarqueur plasmatique marqueur de l&rsquo;activit\u00e9 du masitinib dans le traitement de la SLA<\/a>\n\t<\/h3>\n\n\t<div class=\"entry-meta\"><a href=\"https:\/\/www.ab-science.com\/fr\/2026\/02\/24\/\" title=\"17h52\" class=\"data-link\" rel=\"bookmark\"><time class=\"entry-date updated\" datetime=\"2026-02-24T17:52:32+01:00\">24 f\u00e9vrier 2026<\/time><\/a><\/div>\n\t<div class=\"entry-excerpt\"><p>[vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb] 24\/02\/2026 \u2013\u00a0AB Science annonce l&rsquo;identification d&rsquo;un biomarqueur potentiel pour \u00e9valuer l&rsquo;activit\u00e9 du masitinib dans l&rsquo;implication pathologique de la microglie dans la scl\u00e9rose lat\u00e9rale amyotrophique (SLA) [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n<\/div>\n\t\n<a href=\"https:\/\/www.ab-science.com\/fr\/ab-science-annonce-lidentification-dun-biomarqueur-plasmatique-marqueur-de-lactivite-du-masitinib-dans-le-traitement-de-la-sla\/\" class=\"post-details details-type-link\" aria-label=\"Read more about AB Science annonce l&rsquo;identification d&rsquo;un biomarqueur plasmatique marqueur de l&rsquo;activit\u00e9 du masitinib dans le traitement de la SLA\">Lire la suite<i class=\"dt-icon-the7-arrow-03\" aria-hidden=\"true\"><\/i><\/a>\n\n<\/div><\/article><\/div><div class=\"visible wf-cell\" data-post-id=\"10574\" data-date=\"2026-02-09T17:48:22+01:00\" data-name=\"La FDA a accord\u00e9 le statut de Minor Use in Major Species (MUMS) au Masivet\u00ae\"><article class=\"post project-odd visible no-img post-10574 type-post status-publish format-standard hentry category-2026-fr category-138\" data-name=\"La FDA a accord\u00e9 le statut de Minor Use in Major Species (MUMS) au Masivet\u00ae\" data-date=\"2026-02-09T17:48:22+01:00\">\n\n<div class=\"post-entry-content\">\n\n\t<h3 class=\"entry-title\">\n\t\t<a href=\"https:\/\/www.ab-science.com\/fr\/la-fda-a-accorde-le-statut-de-minor-use-in-major-species-mums-au-masivet\/\" title=\"La FDA a accord\u00e9 le statut de Minor Use in Major Species (MUMS) au Masivet\u00ae\" rel=\"bookmark\">La FDA a accord\u00e9 le statut de Minor Use in Major Species (MUMS) au Masivet\u00ae<\/a>\n\t<\/h3>\n\n\t<div class=\"entry-meta\"><a href=\"https:\/\/www.ab-science.com\/fr\/2026\/02\/09\/\" title=\"17h48\" class=\"data-link\" rel=\"bookmark\"><time class=\"entry-date updated\" datetime=\"2026-02-09T17:48:22+01:00\">9 f\u00e9vrier 2026<\/time><\/a><\/div>\n\t<div class=\"entry-excerpt\"><p>[vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb] 09\/02\/2026 \u2013\u00a0AB Science annonce que la Food and Drug Administration (FDA) am\u00e9ricaine a accord\u00e9 le statut de Minor Use in Major Species (MUMS) au Masivet\u00ae dans le traitement des tumeurs mastocytaires chez le chien [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00a0\u00bb\u00a0\u00bb][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n<\/div>\n\t\n<a href=\"https:\/\/www.ab-science.com\/fr\/la-fda-a-accorde-le-statut-de-minor-use-in-major-species-mums-au-masivet\/\" class=\"post-details details-type-link\" aria-label=\"Read more about La FDA a accord\u00e9 le statut de Minor Use in Major Species (MUMS) au Masivet\u00ae\">Lire la suite<i class=\"dt-icon-the7-arrow-03\" aria-hidden=\"true\"><\/i><\/a>\n\n<\/div><\/article><\/div><\/div><!-- iso-container|iso-grid --><\/div>[\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row css=\u00a0\u00bb.vc_custom_1601559325217{margin-top: 0px !important;padding-top: 0px !important;}\u00a0\u00bb][vc_column][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3983","page","type-page","status-publish","hentry","description-off"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.4 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>AB Science d\u00e9veloppe deux compos\u00e9s principaux, le Masitinib et le AB8939<\/title>\n<meta name=\"description\" content=\"AB Science d\u00e9veloppe actuellement deux compos\u00e9s principaux, le masitinib, un inhibiteur de tyrosine kinase hautement s\u00e9lectif et AB8939.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ab-science.com\/fr\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Accueil\" \/>\n<meta property=\"og:description\" content=\"AB Science d\u00e9veloppe actuellement deux compos\u00e9s principaux, le masitinib, un inhibiteur de tyrosine kinase hautement s\u00e9lectif et AB8939.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ab-science.com\/fr\/\" \/>\n<meta property=\"og:site_name\" content=\"AB Science\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-21T10:28:26+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\",\"name\":\"AB Science d\u00e9veloppe deux compos\u00e9s principaux, le Masitinib et le AB8939\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#website\"},\"datePublished\":\"2020-09-15T12:52:33+00:00\",\"dateModified\":\"2025-05-21T10:28:26+00:00\",\"description\":\"AB Science d\u00e9veloppe actuellement deux compos\u00e9s principaux, le masitinib, un inhibiteur de tyrosine kinase hautement s\u00e9lectif et AB8939.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Accueil\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\",\"name\":\"AB Science\",\"description\":\"Masitinib and AB8939 \u2013 Two compounds with breakthrough mechanism of action\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#organization\",\"name\":\"AB Science\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/logo_ab-science-wh120.png\",\"contentUrl\":\"https:\\\/\\\/www.ab-science.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/logo_ab-science-wh120.png\",\"width\":120,\"height\":120,\"caption\":\"AB Science\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ab-science\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"AB Science d\u00e9veloppe deux compos\u00e9s principaux, le Masitinib et le AB8939","description":"AB Science d\u00e9veloppe actuellement deux compos\u00e9s principaux, le masitinib, un inhibiteur de tyrosine kinase hautement s\u00e9lectif et AB8939.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ab-science.com\/fr\/","og_locale":"fr_FR","og_type":"article","og_title":"Accueil","og_description":"AB Science d\u00e9veloppe actuellement deux compos\u00e9s principaux, le masitinib, un inhibiteur de tyrosine kinase hautement s\u00e9lectif et AB8939.","og_url":"https:\/\/www.ab-science.com\/fr\/","og_site_name":"AB Science","article_modified_time":"2025-05-21T10:28:26+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ab-science.com\/fr\/","url":"https:\/\/www.ab-science.com\/fr\/","name":"AB Science d\u00e9veloppe deux compos\u00e9s principaux, le Masitinib et le AB8939","isPartOf":{"@id":"https:\/\/www.ab-science.com\/fr\/#website"},"datePublished":"2020-09-15T12:52:33+00:00","dateModified":"2025-05-21T10:28:26+00:00","description":"AB Science d\u00e9veloppe actuellement deux compos\u00e9s principaux, le masitinib, un inhibiteur de tyrosine kinase hautement s\u00e9lectif et AB8939.","breadcrumb":{"@id":"https:\/\/www.ab-science.com\/fr\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ab-science.com\/fr\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ab-science.com\/fr\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.ab-science.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Accueil"}]},{"@type":"WebSite","@id":"https:\/\/www.ab-science.com\/fr\/#website","url":"https:\/\/www.ab-science.com\/fr\/","name":"AB Science","description":"Masitinib and AB8939 \u2013 Two compounds with breakthrough mechanism of action","publisher":{"@id":"https:\/\/www.ab-science.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ab-science.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ab-science.com\/fr\/#organization","name":"AB Science","url":"https:\/\/www.ab-science.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ab-science.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ab-science.com\/wp-content\/uploads\/2020\/11\/logo_ab-science-wh120.png","contentUrl":"https:\/\/www.ab-science.com\/wp-content\/uploads\/2020\/11\/logo_ab-science-wh120.png","width":120,"height":120,"caption":"AB Science"},"image":{"@id":"https:\/\/www.ab-science.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/ab-science\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/pages\/3983","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/comments?post=3983"}],"version-history":[{"count":0,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/pages\/3983\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/media?parent=3983"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}